Theravance Biopharma Inc
NASDAQ:TBPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Theravance Biopharma Inc
NASDAQ:TBPH
|
KY |
|
Bruker Corp
NASDAQ:BRKR
|
US |
|
Bubblr Inc
OTC:BBLR
|
US |
|
R
|
Rectitude Holdings Ltd
NASDAQ:RECT
|
SG |
Wall Street
Price Targets
TBPH Price Targets Summary
Theravance Biopharma Inc
According to Wall Street analysts, the average 1-year price target for
TBPH
is 16.93 USD
with a low forecast of 14.14 USD and a high forecast of 22.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TBPH's stock price target?
Price Target
16.93
USD
According to Wall Street analysts, the average 1-year price target for
TBPH
is 16.93 USD
with a low forecast of 14.14 USD and a high forecast of 22.05 USD.
What is Theravance Biopharma Inc's Revenue forecast?
Projected CAGR
-5%
For the last 13 years the
compound annual growth rate for
Theravance Biopharma Inc's revenue is
-1%.
The projected
CAGR
for the next 3 years is
-5%.
What is Theravance Biopharma Inc's Net Income forecast?
Projected CAGR
-27%
The
compound annual growth rate
of Theravance Biopharma Inc's net income for the next 3 years is
-27%.
